105 related articles for article (PubMed ID: 9932710)
1. Effects of accumbens m-chlorophenylbiguanide microinjections on sleep and waking in intact and 6-hydroxydopamine-treated rats.
Monti JM; Ponzoni A; Jantos H; Lagos P; Silveira R; Banchero P
Eur J Pharmacol; 1999 Jan; 364(2-3):89-98. PubMed ID: 9932710
[TBL] [Abstract][Full Text] [Related]
2. Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists.
Ponzoni A; Monti JM; Jantos H; Altier H; Monti D
Eur J Pharmacol; 1995 May; 278(2):111-5. PubMed ID: 7671995
[TBL] [Abstract][Full Text] [Related]
3. The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.
Ponzoni A; Monti JM; Jantos H
Eur J Pharmacol; 1993 Nov; 249(3):259-64. PubMed ID: 8287912
[TBL] [Abstract][Full Text] [Related]
4. Effects of repeated daily treatments with a 5-HT3 receptor antagonist on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus accumbens of Wistar rats.
Liu W; Thielen RJ; McBride WJ
Pharmacol Biochem Behav; 2006 Jun; 84(2):370-7. PubMed ID: 16828150
[TBL] [Abstract][Full Text] [Related]
5. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.
Monti JM; Jantos H
Eur J Pharmacol; 2006 Dec; 553(1-3):163-70. PubMed ID: 17059817
[TBL] [Abstract][Full Text] [Related]
6. Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats.
Mazzola-Pomietto P; Aulakh CS; Murphy DL
Psychopharmacology (Berl); 1995 Oct; 121(4):488-93. PubMed ID: 8619014
[TBL] [Abstract][Full Text] [Related]
7. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
[TBL] [Abstract][Full Text] [Related]
8. Effects of selective activation of the 5-HT1B receptor with CP-94,253 on sleep and wakefulness in the rat.
Monti JM; Monti D; Jantos H; Ponzoni A
Neuropharmacology; 1995 Dec; 34(12):1647-51. PubMed ID: 8788962
[TBL] [Abstract][Full Text] [Related]
9. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
Monti JM; Jantos H
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):940-7. PubMed ID: 18295951
[TBL] [Abstract][Full Text] [Related]
10. Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatment.
Gyongyosi N; Balogh B; Katai Z; Molnar E; Laufer R; Tekes K; Bagdy G
J Neural Transm (Vienna); 2010 Mar; 117(3):285-92. PubMed ID: 20052506
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
Monti JM; Jantos H; Catenaccio V; Xavier S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1341-8. PubMed ID: 21514352
[TBL] [Abstract][Full Text] [Related]
12. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on the discrimination of durations: evidence for the involvement of 5-HT2A but not 5-HT3 receptors.
Asgari K; Body S; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
Behav Pharmacol; 2005 Feb; 16(1):43-51. PubMed ID: 15706137
[TBL] [Abstract][Full Text] [Related]
13. Hypoglossal nerve response to 5-HT3 drugs injected into the XII nucleus and vena cava in the rat.
Fenik P; Ogawa H; Veasey SC
Sleep; 2001 Dec; 24(8):871-8. PubMed ID: 11766156
[TBL] [Abstract][Full Text] [Related]
14. Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone.
Monti JM; Jantos H; Silveira R; Reyes-Parada M; Scorza C
Pharmacol Biochem Behav; 1995 Oct; 52(2):305-12. PubMed ID: 8577795
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic regulation of the central nucleus of the amygdala in rats: effects of local microinjections of cholinomimetics and cholinergic antagonists on arousal and sleep.
Sanford LD; Yang L; Tang X; Dong E; Ross RJ; Morrison AR
Neuroscience; 2006 Sep; 141(4):2167-76. PubMed ID: 16843604
[TBL] [Abstract][Full Text] [Related]
16. Changes in sleep and wakefulness following 5-HT1A ligands given systemically and locally in different brain regions.
Bjorvatn B; Ursin R
Rev Neurosci; 1998; 9(4):265-73. PubMed ID: 9886141
[TBL] [Abstract][Full Text] [Related]
17. Central 5-HT(3) receptors and water intake in rats.
Castro L; Varjão B; Maldonado I; Campos I; Duque B; Fregoneze J; Reis de Oliveira I; De Castro-e-Silva E
Physiol Behav; 2002 Nov; 77(2-3):349-59. PubMed ID: 12419412
[TBL] [Abstract][Full Text] [Related]
18. Central 5-HT2B/2C and 5-HT3 receptor stimulation decreases salt intake in sodium-depleted rats.
Castro L; Athanazio R; Barbetta M; Ramos AC; Angelo AL; Campos I; Varjão B; Ferreira H; Fregoneze J; de Castro e Silva E
Brain Res; 2003 Aug; 981(1-2):151-9. PubMed ID: 12885436
[TBL] [Abstract][Full Text] [Related]
19. Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors.
Morton RA; Baptista-Hon DT; Hales TG; Lovinger DM
Br J Pharmacol; 2015 Aug; 172(16):4066-77. PubMed ID: 25989383
[TBL] [Abstract][Full Text] [Related]
20. Study of the 5-HT2 antagonist ritanserin on sleep-walking cycle in the rat.
Silhol S; Glin L; Gottesmann C
Pharmacol Biochem Behav; 1992 Jan; 41(1):241-3. PubMed ID: 1539075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
